Ketamine alters the aperiodic EEG exponent in major depression: implications for cortical E/I balance and treatment prediction
Therapeutic Advances in Psychopharmacology
Published online on July 04, 2026
Abstract
Therapeutic Advances in Psychopharmacology, Volume 16, January-December 2026.
Background:Ketamine has emerged as a promising rapid-acting antidepressant for treatment-resistant depression (TRD), yet its mechanisms of action and reliable biomarkers of treatment response remain poorly understood. Recent evidence suggests that the ...
Background:Ketamine has emerged as a promising rapid-acting antidepressant for treatment-resistant depression (TRD), yet its mechanisms of action and reliable biomarkers of treatment response remain poorly understood. Recent evidence suggests that the ...